Page last updated: 2024-08-21

glycopyrrolate and Cognition Disorders

glycopyrrolate has been researched along with Cognition Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bahro, M; Conway, A; Dukoff, R; Friz, J; Lasser, R; Peskind, ER; Sunderland, T; Wilkinson, CW	1

Other Studies

1 other study(ies) available for glycopyrrolate and Cognition Disorders

Article	Year
Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers. Biological psychiatry, 1999, Jul-15, Volume: 46, Issue:2 Topics: Aged; Aging; Brief Psychiatric Rating Scale; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Female; Glycopyrrolate; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Injections, Intravenous; Male; Muscarinic Antagonists; Neuronal Plasticity; Physostigmine; Pituitary-Adrenal System; Presynaptic Terminals; Receptors, Muscarinic; Scopolamine; Severity of Illness Index; Time Factors; Up-Regulation	1999

Article

Year

Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.

Biological psychiatry, 1999, Jul-15, Volume: 46, Issue:2

Topics: Aged; Aging; Brief Psychiatric Rating Scale; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Female; Glycopyrrolate; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Injections, Intravenous; Male; Muscarinic Antagonists; Neuronal Plasticity; Physostigmine; Pituitary-Adrenal System; Presynaptic Terminals; Receptors, Muscarinic; Scopolamine; Severity of Illness Index; Time Factors; Up-Regulation

1999